Focal Neurological Involvement in Adult-Onset Still Disease-Associated Haemophagocytic Lymphohistiocytosis: A Diagnostic Challenge
Year: 2026
Type: article
Study design: Case Report
Abstract: A woman in her late 40s with adult-onset Still's disease (AOSD), previously independent in mobility, personal care, and cognition, presented with fever, sore throat, and a diffuse erythematous eruption involving the palms, soles, and lower limbs. Her medical history was also significant for established hepatitis B infection, for which she had been receiving long-term entecavir therapy. Her regular immunomodulatory medications included anakinra 100 mg subcutaneously once daily and methotrexate 20 mg subcutaneously weekly, alongside folic acid; prednisolone had recently been discontinued. Anakinra and methotrexate were temporarily withheld for one week on rheumatology advice due to concerns regarding COVID-19 infection. Investigations revealed marked hyperferritinemia, with ferritin peaking at 23,321 µg/L, hypertriglyceridaemia, hypofibrinogenaemia, liver dysfunction and a peak HScore of 214, a diagnostic scoring system for reactive haemophagocytic syndrome supporting a diagnosis of haemophagocytic lymphohistiocytosis (HLH), also termed macrophage activation syndrome (MAS) in the context of rheumatological disease. A SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) was positive; severe COVID-19 pneumonitis was considered a potential infectious trigger. The patient subsequently developed type 1 respiratory failure requiring admission to the intensive care unit (ICU). Despite treatment with corticosteroids and escalation of anakinra, her clinical course was complicated by profound encephalopathy, aphasia and focal neurological deficits. Magnetic resonance imaging (MRI) demonstrated left temporoparietal restricted diffusion and superficial pial enhancement, while ophthalmological assessment identified a right homonymous hemianopia. Electroencephalography (EEG) demonstrated persistent left hemispheric dysfunction. Despite extensive infectious investigations identifying potential contributing pathogens, no single definitive trigger for HLH/MAS could be established. National multidisciplinary review considered a broad differential diagnosis for the neurological abnormalities, including central nervous system involvement secondary to HLH, peri-ictal changes, cerebral ischaemia, viral infection and occult intravascular lymphoma. This case highlights the diagnostic complexity of HLH/MAS, in which multiple potential triggers and overlapping neurological manifestations may prevent identification of a single underlying aetiology despite extensive investigation. New-onset encephalopathy, aphasia, seizures or focal neurological deficits in patients with HLH/MAS should prompt early neurological assessment, appropriate MRI, EEG and cerebrospinal fluid investigations, and multidisciplinary specialist input. Neuroimaging findings should be interpreted alongside clinical, laboratory and other investigative findings, maintaining a broad differential diagnosis rather than prematurely attributing abnormalities to a single cause.
Source: Cureus
Institution: University Hospitals Birmingham NHS Foundation Trust
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: adult-onset Still's disease, hemophagocytic lymphohistiocytosis, macrophage activation syndrome, focal neurological deficits, encephalopathy, aphasia, homonymous hemianopia, COVID-19 pneumonitis, SARS-CoV-2, hyperferritinemia, anakinra, methotrexate, differential diagnosis, neurological complications
Open Access status: diamond
OpenAlex ID: W7236504864
